Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: March 3, 2001
Last updated: December 18, 2013
Last verified: October 2002